meddevicedb.com FDA Device Reference

FERRITIN MAB SOLID PHASE COMPONENT SYSTEM

K870570 Class II Traditional
Decision Date
1987-03-12
Sponsor / Applicant
Bd Becton Dickinson Vacutainer Systems Preanalytic

Technical Specification

510(k) Submission ID K870570
Product Code DBF
Medical Specialty / Panel Immunology
Regulation Citation 21 CFR 866.5340
Decision Date 1987-03-12
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

FERRITIN MAB SOLID PHASE COMPONENT SYSTEM received FDA 510(k) clearance under submission number K870570, sponsored by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1987-03-12.

Classification & Regulation

This clearance is catalogued under FDA product code DBF and 21 CFR 866.5340, within the Immunology review panel as a Class II device.